Published Reported
HRT for Weight Loss: What the Evidence Says
Some HRT formulations include testosterone, which can increase lean mass and metabolic rate, and at physiologic doses testosterone potentiates insulin signaling in muscle.
In The News
Published Reported
Some HRT formulations include testosterone, which can increase lean mass and metabolic rate, and at physiologic doses testosterone potentiates insulin signaling in muscle.
Published Reported
Some men with obesity and low testosterone may see testosterone improve on GLP-1 receptor agonists, mainly through weight and metabolic improvement rather than a direct effect, and weight loss is first-line for...
Published Reported
Men's average testosterone has fallen 54% since 1972, and the average man today may produce less than half the testosterone his grandfather did at the same age.
Published Reported
Average testosterone in men fell 54% between 1972 and 2019, and researchers linked the decline mainly to rising obesity and diabetes.
Published Reported
Men's average testosterone fell 54% between 1972 and 2019, mainly because of obesity and diabetes, placing male reproductive ability and metabolic health in a grave existential crisis.
Published Reported
Testosterone levels in men have declined by approximately 1% per year across generations, and 1 week of short sleep reduces daytime testosterone by 10% to 15% in healthy young men.
Published Reported
Testosterone may improve body composition, blood sugar and sexual desire in older men at high risk of type 2 diabetes, but only alongside a lifestyle program.
Published Reported
In a 4-year extension of the T4DM trial, testosterone maintained improvements in body composition and sexual desire, blood glucose benefits diminished after 2 years, and the benefits require engagement in a lifestyle...
Published Reported
Testosterone may be prescribed in hormone replacement therapy because it aids fat loss, and expected benefits of therapy include weight loss and reduced body fat, especially belly fat.
Published Reported
In a retrospective analysis of 1,629 obese men treated with semaglutide or tirzepatide, median total testosterone rose from 320 to 419 ng/dL; causality cannot be established.
Shared Decision Making
Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.
Create a free account or log in to save and bookmark articles.